Studies suggest that dietary MUFAs can reduce IL-1β-mediated adipose dysfunction and insulin resistance via preservation of AMP-activated protein kinase (AMPK) activity which, in turn, quenches NLRP3 inflammasome activation [30,45,46]. The gene discussed is IL1B; the disease is Insulin resistance.